Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS.

Trial Profile

Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Cilostazol (Primary)
  • Indications Cerebral infarction; Embolism and thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Korea Otsuka Pharmaceutical
  • Most Recent Events

    • 30 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top